Amaya Celis-Fernandez
Pamplona, NC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Chemerin Activation of Toll-Like Receptor 4 Drives Mineralocorticoid Receptor-Mediated Aortic Valve Remodeling in Chronic Kidney Disease.
Journal: Journal of the American Heart Association
Published: April 16, 2026
Dual transcriptomic profiling of Staphylococcus aureus endocarditis in a porcine model reveals strong parallels with human infection.
Journal: mBio
Published: October 31, 2025
Endogenous α-Klotho is a common target in atherosclerosis and calcific aortic valve disease.
Journal: Biochemical pharmacology
Published: September 19, 2025
Endogenous α-Klotho is a common target in atherosclerosis and calcific aortic valve disease.
Journal: Biochemical pharmacology
Published: September 19, 2025
Chemerin is a new sex-specific target in aortic stenosis concomitant with diabetes regulated by the aldosterone/mineralocorticoid receptor axis.
Journal: American journal of physiology. Heart and circulatory physiology
Published: January 20, 2025
The Presence of Adipose Tissue in Aortic Valves Influences Inflammation and Extracellular Matrix Composition in Chronic Aortic Regurgitation.
Journal: International journal of molecular sciences
Published: January 16, 2025
Sex differences in aortic valve inflammation and remodeling in chronic severe aortic regurgitation.
Journal: American journal of physiology. Heart and circulatory physiology
Published: January 13, 2025
Diagnostic Performance of Serum Leucine-Rich Alpha-2-Glycoprotein 1 in Pediatric Acute Appendicitis: A Prospective Validation Study.
Journal: Biomedicines
Published: May 22, 2024
Mineralocorticoid receptor (MR) antagonist eplerenone and MR modulator balcinrenone prevent renal extracellular matrix remodeling and inflammation via the MR/proteoglycan/TLR4 pathway.
Journal: Clinical science (London, England : 1979)
Published: February 25, 2024
Last Updated: 09/26/2026